BioCentury on BioBusiness,
Emerging Company Profile
ClinMet metabolite panel tracks kidney disease progression, drug efficacy
Related tables, figures and sidebars
ClinMet: Metabolite monitoring
Monday, December 9, 2013
Metabolomics Inc. is using metabolomics to aid product discovery by
finding disease-specific metabolite panels that monitor drug efficacy and
provide insights about the mechanism of action of new products. Its most
advanced tool can distinguish between diabetic kidney disease patients and
healthy controls and could give companies faster readouts about how
their investigational kidney drugs are working, and how well.
The idea for the panel came from work by ClinMet's scientific
founder and SAB chair Kumar Sharma at the University
of California, San Diego, who was searching for biomarkers to track diabetic
kidney disease and determine why some patients are unresponsive to particular
treatments. Sharma is director of the Center for Renal Translational Medicine
and the Institute of Metabolomic Medicine at UCSD.
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2016 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial Subscription 4 Weeks of Access
BioCentury's Weekly Business Intelligence Journal
Get a 4-week free trial subscription to BioCentury.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]